Sagent Pharmaceuticals Announces the Approval and Launch of Zoledronic Acid Injection 4 mg in a Plastic Vial
March 05, 2013 15:54 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., March 5, 2013 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the approval and launch of Zoledronic Acid Injection 4 mg, the generic form of the...
Sagent Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Results
February 14, 2013 07:00 ET
|
Sagent Pharmaceuticals, Inc.
Record Quarterly Revenue and Earnings Driven by New Product Launches
Company Achieves Revised Fiscal Year 2012 Guidance
SCHAUMBURG, Ill., Feb. 14, 2013 (GLOBE NEWSWIRE) -- Sagent...
Sagent Pharmaceuticals Sets Date and Time for Release of Fourth Quarter and Full Year 2012 Financial Results
January 31, 2013 08:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Jan. 31, 2013 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced...
Sagent Pharmaceuticals Announces the Temporary Importation of Sodium Bicarbonate Injection, USP
January 09, 2013 16:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Jan. 9, 2013 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced that due to the current critical shortage of Sodium Bicarbonate Injection, USP in the...
Sagent Pharmaceuticals to Present at 31st Annual J.P. Morgan Healthcare Conference
January 04, 2013 12:43 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Jan. 4, 2013 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with a specific emphasis on the injectable market, today...
Sagent Pharmaceuticals Announces the Launch of Flumazenil Injection, USP
January 02, 2013 16:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Jan. 2, 2013 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced...
Sagent Pharmaceuticals Announces Launch of Nafcillin for Injection, USP
November 28, 2012 08:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Nov. 28, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Nafcillin for Injection, USP, in two vial presentations and one pharmacy...
Sagent Pharmaceuticals Ranked Third Fastest Growing Company in North America on Deloitte's 2012 Technology Fast 500
November 19, 2012 08:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Nov. 19, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced...
Sagent Pharmaceuticals Announces the Launch of Acetazolamide for Injection, USP
November 13, 2012 08:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Nov. 13, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Acetazolamide for Injection, USP, the generic form of the carbonic...
Sagent Pharmaceuticals Reports Third Quarter 2012 Financial Results
November 08, 2012 07:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Nov. 8, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced financial results for the quarter ended September 30, 2012.
Third Quarter 2012...